Literature DB >> 32833011

Abundance and localization of human UBE3A protein isoforms.

Carissa L Sirois1, Judy E Bloom2,3, James J Fink3, Dea Gorka1, Steffen Keller4, Noelle D Germain1, Eric S Levine3, Stormy J Chamberlain1,5.   

Abstract

Loss of UBE3A expression, a gene regulated by genomic imprinting, causes Angelman syndrome (AS), a rare neurodevelopmental disorder. The UBE3A gene encodes an E3 ubiquitin ligase with three known protein isoforms in humans. Studies in mouse suggest that the human isoforms may have differences in localization and neuronal function. A recent case study reported mild AS phenotypes in individuals lacking one specific isoform. Here we have used CRISPR/Cas9 to generate isogenic human embryonic stem cells (hESCs) that lack the individual protein isoforms. We demonstrate that isoform 1 accounts for the majority of UBE3A protein in hESCs and neurons. We also show that UBE3A predominantly localizes to the cytoplasm in both wild type and isoform-null cells. Finally, we show that neurons lacking isoform 1 display a less severe electrophysiological AS phenotype.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 32833011      PMCID: PMC7645711          DOI: 10.1093/hmg/ddaa191

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

1.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

2.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

3.  Zinc finger protein 274 regulates imprinted expression of transcripts in Prader-Willi syndrome neurons.

Authors:  Maéva Langouët; Heather R Glatt-Deeley; Michael S Chung; Clémence M Dupont-Thibert; Elodie Mathieux; Erin C Banda; Christopher E Stoddard; Leann Crandall; Marc Lalande
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

4.  Allelic specificity of Ube3a expression in the mouse brain during postnatal development.

Authors:  Matthew C Judson; Jason O Sosa-Pagan; Wilmer A Del Cid; Ji Eun Han; Benjamin D Philpot
Journal:  J Comp Neurol       Date:  2014-06-01       Impact factor: 3.215

5.  The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain.

Authors:  C Rougeulle; H Glatt; M Lalande
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

6.  Small molecules enhance CRISPR genome editing in pluripotent stem cells.

Authors:  Chen Yu; Yanxia Liu; Tianhua Ma; Kai Liu; Shaohua Xu; Yu Zhang; Honglei Liu; Marie La Russa; Min Xie; Sheng Ding; Lei S Qi
Journal:  Cell Stem Cell       Date:  2015-02-05       Impact factor: 24.633

7.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; R D Vierstra; P M Howley
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

8.  The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons.

Authors:  Sheng Miao; Renchao Chen; Jiahao Ye; Guo-He Tan; Shuai Li; Jing Zhang; Yong-hui Jiang; Zhi-Qi Xiong
Journal:  J Neurosci       Date:  2013-01-02       Impact factor: 6.167

Review 9.  Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.

Authors:  Janine M LaSalle; Lawrence T Reiter; Stormy J Chamberlain
Journal:  Epigenomics       Date:  2015-11-20       Impact factor: 4.778

10.  Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome.

Authors:  Rossella Avagliano Trezza; Monica Sonzogni; Stijn N V Bossuyt; F Isabella Zampeta; A Mattijs Punt; Marlene van den Berg; Diana C Rotaru; Linda M C Koene; Shashini T Munshi; Jeffrey Stedehouder; Johan M Kros; Mark Williams; Helen Heussler; Femke M S de Vrij; Edwin J Mientjes; Geeske M van Woerden; Steven A Kushner; Ben Distel; Ype Elgersma
Journal:  Nat Neurosci       Date:  2019-06-24       Impact factor: 24.884

View more
  11 in total

1.  Two siblings suffering from Angelman Syndrome with a novel c.1146T>G mutation in UBE3A: A case report.

Authors:  Can Liu; Rui-Hua Liu; Guang-Fei Sun; Lin Yang; Qin-Liang Zheng; Shan-Ying Wei; Qing-Xia Kong; Qiu-Bo Li
Journal:  Biomed Rep       Date:  2022-04-19

2.  Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.

Authors:  Stijn N V Bossuyt; A Mattijs Punt; Ilona J de Graaf; Janny van den Burg; Mark G Williams; Helen Heussler; Ype Elgersma; Ben Distel
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

Review 3.  UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome.

Authors:  Ype Elgersma; Monica Sonzogni
Journal:  Dev Med Child Neurol       Date:  2021-02-04       Impact factor: 5.449

4.  A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets.

Authors:  Nikhil J Pandya; Sonja Meier; Stefka Tyanova; Marco Terrigno; Congwei Wang; A Mattijs Punt; E J Mientjes; Audrey Vautheny; Ben Distel; Thomas Kremer; Ype Elgersma; Ravi Jagasia
Journal:  Mol Psychiatry       Date:  2022-03-09       Impact factor: 13.437

Review 5.  Molecular Evolution, Neurodevelopmental Roles and Clinical Significance of HECT-Type UBE3 E3 Ubiquitin Ligases.

Authors:  Mateusz C Ambrozkiewicz; Katherine J Cuthill; Dermot Harnett; Hiroshi Kawabe; Victor Tarabykin
Journal:  Cells       Date:  2020-11-10       Impact factor: 6.600

6.  Evaluation of UBE3A antibodies in mice and human cerebral organoids.

Authors:  Dilara Sen; Zuzana Drobna; Albert J Keung
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

7.  Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice.

Authors:  Matthew C Judson; Charles Shyng; Jeremy M Simon; Courtney R Davis; A Mattijs Punt; Mirabel T Salmon; Noah W Miller; Kimberly D Ritola; Ype Elgersma; David G Amaral; Steven J Gray; Benjamin D Philpot
Journal:  JCI Insight       Date:  2021-10-22

Review 8.  GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy.

Authors:  Maya Chopra; Meera E Modi; Kira A Dies; Nancy L Chamberlin; Elizabeth D Buttermore; Stephanie Jo Brewster; Lisa Prock; Mustafa Sahin
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-29       Impact factor: 5.849

9.  Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A.

Authors:  Dilara Sen; Alexis Voulgaropoulos; Zuzana Drobna; Albert J Keung
Journal:  Stem Cell Reports       Date:  2020-09-10       Impact factor: 7.765

10.  Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms.

Authors:  F Isabella Zampeta; Monica Sonzogni; Eva Niggl; Bas Lendemeijer; Hilde Smeenk; Femke M S de Vrij; Steven A Kushner; Ben Distel; Ype Elgersma
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.